Field therapy options for widespread sun damage and multiple lesions
Bring a printable list of questions to your appointment, or share this page with someone who needs it.
If your dermatologist counts three, five, or a dozen actinic keratoses across your scalp, forehead, or forearms in a single visit, freezing each one off individually starts to look less like a plan and more like a whack-a-mole game you can't win. That's not a coincidence — when AKs cluster this way, it usually means the surrounding skin carries widespread, sun-damaged cells that haven't become visible spots yet. Treating only what you can see leaves that reservoir of damage untouched, and new AKs keep surfacing from it.
This is where the approach genuinely changes. Instead of, or in addition to, treating individual lesions, your dermatologist will likely recommend "field therapy" — a treatment applied across the whole affected area. This article goes deep on how the specific field-therapy options work, how they compare to spot treatment, what the treatment course actually feels like day to day, and how to combine approaches when one alone isn't enough. For a broader overview of all AK treatment types, including cryotherapy and curettage, see our guide to AK treatment options.
Cryotherapy (freezing) is quick, effective, and ideal when you have one, two, or a handful of well-defined AKs. It destroys exactly the tissue the applicator touches — nothing more, nothing less. That precision is also its limitation: it does nothing for the sun-damaged cells one centimeter away that haven't yet become a visible rough patch.
Field therapy accepts a trade-off in the opposite direction. It's slower and less immediately dramatic than freezing off a single spot, but it treats an entire region — the visible AKs and the "subclinical" ones your dermatologist can predict are there but can't yet see or feel. For someone with a handful of scattered AKs, cryotherapy alone may be entirely reasonable. For someone with a field of damage across the scalp, forehead, or forearms, field therapy addresses the underlying problem in a way that spot-treating each new bump as it appears never quite catches up to.
The 2021 American Academy of Dermatology guidelines give strong recommendations to two topical field agents — 5-fluorouracil and imiquimod — and conditional recommendations to photodynamic therapy and diclofenac gel. Here's how each actually works and what a typical course looks like.
A topical chemotherapy cream that blocks DNA synthesis in rapidly dividing cells, causing damaged keratinocytes to die off while largely sparing normal skin. In the largest head-to-head trial of field therapies, 5-FU produced the highest clearance rate of the options tested.
Typical regimen: applied once or twice daily for 2 to 4 weeks, though some dermatologists use shorter, more intensive courses or a "pulsed" once-weekly schedule repeated seasonally. It is the field treatment most consistently rated the most effective across studies, though also usually the most irritating.
Rather than directly killing cells, imiquimod stimulates the immune system to recognize and clear abnormal keratinocytes — it's an immune-response modifier, not a chemotherapy agent. It's typically applied 2 to 3 times per week for 12 to 16 weeks (regimens vary by strength and product). Because it works through inflammation rather than direct cytotoxicity, some patients find it more tolerable day-to-day than 5-FU, though the treatment course runs considerably longer.
A photosensitizing solution (aminolevulinic acid or methyl aminolevulinate) is applied in-office and left on the skin for one to several hours, then activated with a specific wavelength of light. The light triggers a reaction that selectively destroys damaged cells. PDT is done in one or two office visits rather than weeks of at-home application, which appeals to patients who worry about sticking with a long home regimen — though it involves a genuinely uncomfortable stinging or burning sensation during the light exposure itself, and can require a day or two of sun avoidance afterward.
An anti-inflammatory (NSAID) gel applied twice daily for 60 to 90 days. It's generally the gentlest of the topical field options in terms of day-to-day irritation, which makes it a reasonable choice for thinner or more sensitive skin — but that gentler reaction profile also tends to come with a more modest clearance rate compared with 5-FU or imiquimod.
Ingenol mebutate gel (brand name Picato) was once a popular field option because of its very short course — just 2 to 3 days of application. However, it was withdrawn from the market (the EU suspended its marketing authorization in 2020, and the manufacturer subsequently withdrew it in other markets including Canada) after safety reviews found a higher rate of skin malignancy in patients who used it compared with those who used imiquimod. If you've read about ingenol mebutate online, know that it's no longer a treatment your dermatologist is likely to offer.
A large randomized trial published in the New England Journal of Medicine followed 624 patients with multiple AKs on the face or scalp, randomly assigned to 5-FU cream, imiquimod cream, methyl aminolevulinate PDT, or ingenol mebutate gel. At 12 months after treatment, the proportion of patients who had at least a 75% reduction in AK lesions was highest with 5-FU (75%), followed by imiquimod (54%), PDT (38%), and ingenol mebutate (29%).
These numbers are useful for context, not for choosing your own treatment in isolation — the trial only studied the face and scalp, and the "best" option for you depends on how much irritation you can tolerate, how reliably you can stick to a home regimen, how large and where the treatment area is, and whether office visits or at-home application fits your life better. This is exactly the kind of tradeoff worth discussing directly with your dermatologist.
Field therapy and spot treatment aren't mutually exclusive, and dermatologists often combine them. A common pattern: cryotherapy on the one or two thickest, most clinically obvious AKs at the same visit a field agent is prescribed for the surrounding area — treating what's visible immediately while the field therapy works on the subclinical damage over the following weeks.
There's also evidence for combining field therapies with each other. Applying 5-FU before a course of daylight PDT, for example, has been shown to improve clearance rates compared with either treatment alone, likely because the 5-FU helps disrupt the surface layer of skin so the photosensitizer penetrates more effectively. Your dermatologist may suggest a sequenced or combined regimen if you've had limited success with a single approach in the past.
Nearly every field therapy follows the same emotional arc, and knowing this in advance makes a real difference in whether patients finish the course: it gets worse before it gets better.
PDT has a different, more compressed timeline: the discomfort is concentrated in the treatment session itself (a stinging or burning sensation during light exposure), followed by redness and peeling over the following several days to a week — a shorter overall reaction window than most topical courses, at the cost of a more intense in-the-moment experience.
Having many AKs doesn't mean you're facing a harder version of the same treatment — it means the underlying problem is different, and the treatment should be too. Field therapy exists specifically to address sun damage that spreads wider than what you can see, using medications and light-based treatments studied and refined over decades to clear that damage with reasonable, predictable side effects.
The reaction during treatment can look worse than the AKs it's treating, but that's the expected, temporary cost of clearing damage that would otherwise keep resurfacing as new spots for years to come. Talk to your dermatologist about which field option — or combination — fits your skin and your life.
Disclaimer: This article is for educational purposes only and not a substitute for professional medical advice. Only a dermatologist examining your skin in person can determine which field therapy, spot treatment, or combination is appropriate for your specific case.
Chat with our AI guide for personalized information about actinic keratosis and skin cancer
Chat with the Navigator